Firms

Founded

—

Type

Venture capital

Team

No team members on record yet.

Co-investing

British Patient Capital

• Maxion Therapeutics$72M · 2025-03-17
• Maxion Therapeutics Ltd.$72M · 2025
• Maxion$72M · Unknown date

General Catalyst

• Maxion Therapeutics$72M · 2025-03-17
• Maxion Therapeutics Ltd.$72M · 2025
• Maxion$72M · Unknown date

LifeArc Ventures

• Maxion Therapeutics$72M · 2025-03-17
• Maxion Therapeutics Ltd.$72M · 2025
• Maxion$72M · Unknown date

Solasta Ventures

• Maxion Therapeutics$72M · 2025-03-17
• Maxion Therapeutics Ltd.$72M · 2025
• Maxion$72M · Unknown date

Monograph Capital

• Maxion Therapeutics$72M · 2025-03-17
• Maxion$72M · Unknown date

SHOW MORE

Investments

$72M2025-03-17	Maxion Therapeutics	General Catalyst, LifeArc Ventures, Monograph Capital, BGF, Solasta Ventures, British Patient Capital
$72M2025	Maxion Therapeutics Ltd.	General Catalyst, LifeArc Ventures, BGF, Solasta Ventures, British Patient Capital, Eli Lilly
$—Unknown date	Senso	Y Combinator, Inovia Capital, BGF, Luge Capital
$72MUnknown date	Maxion	General Catalyst, LifeArc Ventures, Monograph Capital, BGF, Solasta Ventures, British Patient Capital

SHOW MORE